Clinical Trial

Prednisone Plus IVIg vs. Prednisone for ITP During Pregnancy

Study acronym: IVIg
Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated August 29, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective, randomized, open-label, multicenter clinical trial study to compare the efficacy and safety of prednisone plus IVIg to prednisone monotherapy in the treatment of immune thrombocytopenia (ITP) in pregnancy.
Trial Details
NCT Number NCT06577909
Lead Sponsor Peking University People's Hospital
Conditions Immune Thrombocytopenia
Enrollment 100 participants
Start Date 2023-10-19
Primary Completion 2024-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-29